Anne N. Heirman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anne N. Heirman has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Lisette van der Molen
Department of Head‐and‐Neck Oncology and Surgery Netherlands Cancer Institute – Antoni van Leeuwenhoek Amsterdam The Netherlands
4 shared publications- Michiel Wilhelmus Maria van Den Brekel
Department of Head and Neck Oncology and Surgery The Netherlands Cancer Institute Amsterdam The Netherlands
4 shared publications Richard Dirven
Department of Head‐and‐Neck Oncology and Surgery Netherlands Cancer Institute – Antoni van Leeuwenhoek Amsterdam The Netherlands
4 shared publicationsFrank Hoebers
Department of Radiation Oncology (Maastro) GROW School for Oncology and Reproduction, Maastricht University Medical Centre Maastricht The Netherlands
2 shared publicationsGyorgy B. Halmos
Department of Otolaryngology/Head and Neck Surgery University of Groningen, University Medical Center Groningen Groningen The Netherlands
2 shared publications- Gyorgy Bela Halmos
University Medical Center Groningen 4 Department of Otorhinolaryngology – Head and Neck Surgery Groningen, the Netherlands
2 shared publications
Latest Publications
- Open Access
- 20 June 2026
- Published by Elsevier in Patient Education and Counseling
- Vol. 151, 109751
Are patient goals discussed during treatment decision-making in patients with head and neck cancer? A qualitative content analysis of consultations
- 20 June 2026
- Published by Elsevier in Patient Education and Counseling
- Vol. 151, 109751
Open AccessAre patient goals discussed during treatment decision-making in patients with head and neck cancer? A qualitative content analysis of consultations
- Open Access
- 4 March 2025
- Published by Elsevier in Patient Education and Counseling
- Vol. 135, 108733
Exploring the state of shared decision-making in head and neck oncology: Assessing treatment communication
- 4 March 2025
- Published by Elsevier in Patient Education and Counseling
- Vol. 135, 108733
Open AccessExploring the state of shared decision-making in head and neck oncology: Assessing treatment communication
- Open Access
- 17 February 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (8) , 3604-3610
Decisional Conflict in Patients with Advanced Laryngeal Carcinoma: A Multicenter Study
Objectives: Decision‐making for patients with a locally advanced laryngeal carcinoma (T3 and T4) is challenging due to the treatment choice between organ preservation and laryngectomy, both with different and high impact on function and quality of life (QoL). The complexity of these treatment decisions and their possible consequences might lead to decisional conflict (DC). This study aimed to explore the level of DC in locally advanced laryngeal carcinoma patients facing curative decision‐making, and to identify possible associated factors.Methods: In this multicenter prospective cohort study, participants completed questionnaires on DC, level of shared decision‐making (SDM), and a knowledge test directly after counseling and 6 months after treatment. Descriptive statistics and Spearman correlation tests were used to analyze the data.Results: Directly after counseling, almost all participants (44/45; 98%) experienced Clinically Significant DC score (CSDC >25, scale 0–100). On average, patients scored 47% (SD 20%) correct on the knowledge test. Questions related to radiotherapy were answered best (69%, SD 29%), whilst only 35% (SD 29%) of the questions related to laryngectomy were answered correctly. Patients' perceived level of SDM (scale 0–100) was 70 (mean, SD 16.2), and for physicians this was 70 (SD 1.7).Conclusion: Most patients with advanced larynx cancer experience high levels of DC. Low knowledge levels regarding treatment aspects indicate a need for better patient counseling.Level of Evidence: 4 Laryngoscope, 134:3604–3610, 2024
- 17 February 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (8) , 3604-3610
Open AccessDecisional Conflict in Patients with Advanced Laryngeal Carcinoma: A Multicenter Study
Objectives: Decision‐making for patients with a locally advanced laryngeal carcinoma (T3 and T4) is challenging due to the treatment choice between organ preservation and laryngectomy, both with different and high impact on function and quality of life (QoL). The complexity of these treatment decisions and their possible consequences might lead to decisional conflict (DC). This study aimed to explore the level of DC in locally advanced laryngeal carcinoma patients facing curative decision‐making, and to identify possible associated factors.Methods: In this multicenter prospective cohort study, participants completed questionnaires on DC, level of shared decision‐making (SDM), and a knowledge test directly after counseling and 6 months after treatment. Descriptive statistics and Spearman correlation tests were used to analyze the data.Results: Directly after counseling, almost all participants (44/45; 98%) experienced Clinically Significant DC score (CSDC >25, scale 0–100). On average, patients scored 47% (SD 20%) correct on the knowledge test. Questions related to radiotherapy were answered best (69%, SD 29%), whilst only 35% (SD 29%) of the questions related to laryngectomy were answered correctly. Patients' perceived level of SDM (scale 0–100) was 70 (mean, SD 16.2), and for physicians this was 70 (SD 1.7).Conclusion: Most patients with advanced larynx cancer experience high levels of DC. Low knowledge levels regarding treatment aspects indicate a need for better patient counseling.Level of Evidence: 4 Laryngoscope, 134:3604–3610, 2024
- Open Access
- 22 December 2023
- Published by Elsevier in Oral Oncology
- Vol. 149, 106677
The development of a decision aid for patients with operable oropharyngeal carcinoma in the Netherlands – A mixed methods study
- 22 December 2023
- Published by Elsevier in Oral Oncology
- Vol. 149, 106677
Open AccessThe development of a decision aid for patients with operable oropharyngeal carcinoma in the Netherlands – A mixed methods study
- Open Access
- 14 August 2023
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 143 (8) , 721-729
The acceptance and voice quality of a new voice prosthesis ‘Vega High performance’ – a feasibility study
Background: The Provox Vega High Performance (PVHP) is a newly developed voice prosthesis (VP) with an aim to achieve a longer and more predictable lifetime. Objectives: This feasibility study aims to assess patient acceptance of the PVHP VP, evaluate adverse events, voice quality, and device lifetime. Methods: Laryngectomized patients previously using a Provox Vega or ActiValve Light were included. Acceptance and voice outcomes were evaluated at two-time points with a 2-week interval. Baseline measurements were taken with the standard VP, followed by placement of the PVHP for the 2-week assessment. Results: Fifteen participants completed the study, with thirteen being initial Vega-users. PVHP acceptance was 87% 2 weeks after placement. Median device lifetime for all VPs was 64 d (range 14-370). In the subgroup without periprosthetic leakage, the median device lifetime was 101 d (range 31-370). Acceptance dropped to 40% after device failure. Voice quality did not differ between PVHP and baseline VP. The most reported adverse event was PVHP valve stickiness (46%). Conclusion and significance: Acceptance of the PVHP is largely dependent on device lifetime, decreasing from 87% to 40% after leakage or replacement. Voice quality remains consistent across different VPs. Developing a long-lasting VP remains a challenge.
- 14 August 2023
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 143 (8) , 721-729
Open AccessThe acceptance and voice quality of a new voice prosthesis ‘Vega High performance’ – a feasibility study
Background: The Provox Vega High Performance (PVHP) is a newly developed voice prosthesis (VP) with an aim to achieve a longer and more predictable lifetime. Objectives: This feasibility study aims to assess patient acceptance of the PVHP VP, evaluate adverse events, voice quality, and device lifetime. Methods: Laryngectomized patients previously using a Provox Vega or ActiValve Light were included. Acceptance and voice outcomes were evaluated at two-time points with a 2-week interval. Baseline measurements were taken with the standard VP, followed by placement of the PVHP for the 2-week assessment. Results: Fifteen participants completed the study, with thirteen being initial Vega-users. PVHP acceptance was 87% 2 weeks after placement. Median device lifetime for all VPs was 64 d (range 14-370). In the subgroup without periprosthetic leakage, the median device lifetime was 101 d (range 31-370). Acceptance dropped to 40% after device failure. Voice quality did not differ between PVHP and baseline VP. The most reported adverse event was PVHP valve stickiness (46%). Conclusion and significance: Acceptance of the PVHP is largely dependent on device lifetime, decreasing from 87% to 40% after leakage or replacement. Voice quality remains consistent across different VPs. Developing a long-lasting VP remains a challenge.
- Open Access
- 21 June 2023
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 138 (2) , 216-223
Maximal cardiopulmonary exercise testing in laryngectomised patients using different heat and moisture exchangers – feasibility and exercise responses
Objective: After laryngectomy, the breathing resistance of heat and moisture exchangers may limit exercise capacity. Breathing gas analysis during cardiopulmonary exercise testing is not possible using regular masks. This study tested the feasibility of cardiopulmonary exercise testing with a heat and moisture exchanger in situ, using an in-house designed connector. Additionally, we explored the effect of different heat and moisture exchanger resistances on exercise capacity in this group.Methods: Ten participants underwent two cardiopulmonary exercise tests using their daily life heat and moisture exchanger (0.3 hPa or 0.6 hPa) and one specifically developed for activity (0.15 hPa). Heat and moisture exchanger order was randomised and blinded.Results: All participants completed both tests. No (serious) adverse events occurred. Only four subjects reached a respiratory exchange ratio of more than 1.1 in at least one test. Maximum exercise levels using heat and moisture exchangers with different resistances did not differ.Conclusion: Cardiopulmonary exercise testing in laryngectomees with a heat and moisture exchanger is feasible; however, the protocol does not seem appropriate to reach this group's maximal exercise capacity. Lowering heat and moisture exchanger resistance does not increase exercise capacity in this sample.
- 21 June 2023
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 138 (2) , 216-223
Open AccessMaximal cardiopulmonary exercise testing in laryngectomised patients using different heat and moisture exchangers – feasibility and exercise responses
Objective: After laryngectomy, the breathing resistance of heat and moisture exchangers may limit exercise capacity. Breathing gas analysis during cardiopulmonary exercise testing is not possible using regular masks. This study tested the feasibility of cardiopulmonary exercise testing with a heat and moisture exchanger in situ, using an in-house designed connector. Additionally, we explored the effect of different heat and moisture exchanger resistances on exercise capacity in this group.Methods: Ten participants underwent two cardiopulmonary exercise tests using their daily life heat and moisture exchanger (0.3 hPa or 0.6 hPa) and one specifically developed for activity (0.15 hPa). Heat and moisture exchanger order was randomised and blinded.Results: All participants completed both tests. No (serious) adverse events occurred. Only four subjects reached a respiratory exchange ratio of more than 1.1 in at least one test. Maximum exercise levels using heat and moisture exchangers with different resistances did not differ.Conclusion: Cardiopulmonary exercise testing in laryngectomees with a heat and moisture exchanger is feasible; however, the protocol does not seem appropriate to reach this group's maximal exercise capacity. Lowering heat and moisture exchanger resistance does not increase exercise capacity in this sample.